Brooks Laboratories Limited (NSE:BROOKS)
India · Delayed Price · Currency is INR 66.68
-1.32 (-1.94%)
Jun 19, 2026, 3:28 PM IST
Brooks Laboratories Market Cap
Brooks Laboratories has a market cap or net worth of 1.96 billion as of June 18, 2026. Its market cap has decreased by -53.98% in one year.
Market Cap
1.96B
Enterprise Value
1.97B
Revenue
857.38M
Ranking
n/a
PE Ratio
7.99
Stock Price
66.68
Market Cap Chart
Since September 5, 2011, Brooks Laboratories's market cap has increased from 105.21M to 1.96B, an increase of 1,766.91%. That is a compound annual growth rate of 21.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 1.96B | -16.80% |
| Dec 31, 2025 | 2.36B | -50.07% |
| Dec 31, 2024 | 4.73B | 25.45% |
| Dec 29, 2023 | 3.77B | 39.59% |
| Dec 30, 2022 | 2.70B | 8.92% |
| Dec 31, 2021 | 2.48B | 51.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 14.25B |
| Sigachi Industries | 8.77B |
| Bafna Pharmaceuticals | 3.79B |
| Valiant Laboratories | 3.69B |
| Nectar Lifesciences | 2.22B |
| Alpa Laboratories | 1.43B |
| Balaxi Pharmaceuticals | 1.31B |
| Par Drugs and Chemicals | 1.16B |